Charles J. Milrod, MD
Clinical Instructor
Boston University Chobanian & Avedisian School of Medicine
General Internal Medicine

Dr. Milrod completed his medical school education at Drexel University College of Medicine, followed by his current residency at Boston Medical Center/Chobanian and Avedisian School of Medicine. During his internal medicine residency at BU, Dr. Milrod described the previously unrecognized adverse event of immune therapy causing skin darkening in Black patients under mentorship of Dr. J. Mark Sloan, MD. Dr. Milrod belongs to several hematology & oncology research societies including the American Society of Hematology and American Society of Clinical Oncology. His work has been published in academic journals including Blood, American Journal of Medicine and others.

As a member of the internal medicine residency at BMC, Dr. Milrod works in a multidisciplinary team to diagnose, coordinate, and optimize treatment for a wide array of diseases in multiple subspecialties. He conducts clinical research, retrospective reviews, and systematic analyses with targeted agents and immune therapies in cancers including multiple myeloma, pancreatic cancer, and lung cancer. Future goals include fellowship in hematology/oncology with a focus on inclusive clinical trial design. Originally from Westfield, NJ, he is a fierce pizza fan.

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Milrod CJ, Kim KW, Raker C, Ollila TA, Olszewski AJ, Pelcovits A. Progression-free survival is a weakly predictive surrogate end-point for overall survival in follicular lymphoma: A systematic review and meta-analysis. Br J Haematol. 2024 Apr 04. PMID: 38571449
  2. Milrod CJ, Binney G, Khan MA. Pancytopenia associated with bone marrow infiltration from late relapse of neuroblastoma. Lancet Oncol. 2023 Dec; 24(12):e519. PMID: 38040004
  3. Hadfield MJ, Milrod CJ, Hsu A, Freeman N. Post-Transfusion Hemophagocytosis Without Evidence of Hemophagocytic Lymphohistiocytosis (HLH). R I Med J (2013). 2023 Mar 01; 106(2):20. PMID: 36848536
  4. Milrod CJ, Mann M, Blevins F, Hughes D, Patel P, Li KY, Lerner A, Sanchorawala V, Sloan JM. Underrepresentation of Black participants and adverse events in clinical trials of lenalidomide for myeloma. Crit Rev Oncol Hematol. 2022 Apr; 172:103644.View Related Profiles. PMID: 35227897; DOI: 10.1016/j.critrevonc.2022.103644;
  5. Milrod CJ, Blevins F, Hughes D, Lerner A, Sarosiek S, Sanchorawala V, Sloan JM. Incidence of skin hyperpigmentation in Black patients receiving treatment with immunomodulatory drugs. Blood. 2021 05 27; 137(21):2987-2989.View Related Profiles. PMID: 33728443
  6. Hildebrand LA, Dumas B, Milrod CJ, Hudspeth JC. Folate Deficiency in an Urban Safety Net Population. Am J Med. 2021 10; 134(10):1265-1269.View Related Profiles. PMID: 34051149
  7. Singh N, Rosenthaler M, Milrod C. Elevated Ferritin in ESRD Patients from Developing Countries. Austin Journal of Clinical Case Reports. 2020; 7(4):1177.
  8. Milrod CJ, Ivan Z, McCarter, K. Gas and (kidney) beans - a dangerous complication of a common infection. Visual journal of emergency medicine. 2020; 21:100817. View Publication
  9. Milrod C, Lockstein D, Torre, M. Cutaneous hyperpigmentation as a side effect of amiodarone. Visual journal of emergency medicine. 2020; 19:100685. View Publication
  10. Williams J, Ima S, Milrod C, Krishnamurthy M. Left lower quadrant pain: an unlikely diagnosis in a case of acute abdomen. J Community Hosp Intern Med Perspect. 2018; 8(5):296-299. PMID: 30357010; PMCID: PMC6197027; DOI: 10.1080/20009666.2018.1517578;
Showing 10 of 12 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 12 publications over 8 distinct years, with a maximum of 3 publications in 2020


In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Multiple myeloma
Immunomodulatory drugs
Health equity
Contact for Mentoring:

Milrod's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department